Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Are Wall Street Analysts Predicting CRH Stock Will Climb or Sink?

With a market cap of $74.4 billion, CRH plc (CRH) is a leading provider of building materials and infrastructure solutions, serving markets across Ireland, the United States, the United Kingdom, Europe, and other international regions. It manufactures and supplies a wide range of products, including cement, aggregates, concrete, asphalt, precast concrete, and outdoor living solutions for residential, commercial, and large-scale infrastructure projects.

Shares of the Dublin, Ireland-based company have underperformed the broader market over the past 52 weeks. CRH stock has returned 11.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 25.6%. Moreover, shares of the company have declined 12.4% on a YTD basis, compared to SPX's nearly 8% rise.

 

Looking closer, shares of CRH have lagged behind the State Street Materials Select Sector SPDR ETF's (XLB21.1% increase over the past 52 weeks.

www.barchart.com

Shares of CRH rose 4.4% on Apr. 30 after the company reported stronger-than-expected Q1 2026 results, with total revenue increasing 9% year-over-year to $7.4 billion and adjusted EBITDA rising 18% to $600 million, while EBITDA margin improved to 8%. Investor sentiment was further boosted by CRH reaffirming its full-year 2026 guidance, including expected net income of $3.9 billion to $4.1 billion and adjusted EBITDA of $8.1 billion to $8.5 billion. 

For the fiscal year ending in December 2026, analysts expect CRH's EPS to grow 6.6% year-over-year at $5.94. The company's earnings surprise history is mixed. It has exceeded or met the consensus estimates in three of the last four quarters while missing on three other occasions. 

Among the 21 analysts covering the stock, the consensus rating is a “Strong Buy.” That’s based on 19 “Strong Buy” ratings, one “Moderate Buy,” and one “Hold.” 

www.barchart.com

On Mar. 3, JPMorgan raised its price target for CRH to $140 and maintained an “Overweight” rating.

The mean price target of $145.89 represents a 31.4% premium to CRH’s current price levels. The Street-high price target of $163 suggests a 46.8% potential upside.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.